Hypoxia-mediated cancer stem cell resistance and targeted therapy

Biomed Pharmacother. 2020 Oct:130:110623. doi: 10.1016/j.biopha.2020.110623. Epub 2020 Aug 10.

Abstract

Drug resistance is a major obstacle in the treatment of tumors, which easily lead to relapse or poor prognosis. Cancer stem cells (CSCs) are regarded as one of the important targets that mediate tumor resistance. Increasing evidence shows that the tumor hypoxia microenvironment is closely related to the resistance of CSCs to chemotherapy and radiotherapy. In this review, we intend to review the articles that have described how the hypoxic microenvironment affects CSC stemness and mediates tumor resistance and provide new directions and methods in the clinical treatment of tumors. Here, we also discuss the feasibility and development prospects of using hypoxia-inducible factors (HIFs) that regulate the hypoxic microenvironment of tumors as targeted agents to treat tumors, as well as to reduce or even reverse the resistance of tumors to chemotherapy and radiotherapy.

Keywords: Cancer stem cells (CSCs); HIF inhibitors; Hypoxia inducible factors (HIFs); Tumor resistance.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Drug Resistance, Neoplasm / drug effects*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hypoxia / pathology*
  • Hypoxia-Inducible Factor 1 / pharmacology*
  • Hypoxia-Inducible Factor 1 / therapeutic use
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / pathology*
  • Tumor Microenvironment / drug effects

Substances

  • Antineoplastic Agents
  • Hypoxia-Inducible Factor 1